These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 12584169
1. 2-Methoxyestradiol interferes with NF kappa B transcriptional activity in primitive neuroectodermal brain tumors: implications for management. Kumar AP, Garcia GE, Orsborn J, Levin VA, Slaga TJ. Carcinogenesis; 2003 Feb; 24(2):209-16. PubMed ID: 12584169 [Abstract] [Full Text] [Related]
2. 2-methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells. Kumar AP, Garcia GE, Slaga TJ. Mol Carcinog; 2001 Jul; 31(3):111-24. PubMed ID: 11479920 [Abstract] [Full Text] [Related]
3. Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress. Kokkinakis DM, Liu X, Chada S, Ahmed MM, Shareef MM, Singha UK, Yang S, Luo J. Cancer Res; 2004 Oct 15; 64(20):7513-25. PubMed ID: 15492278 [Abstract] [Full Text] [Related]
4. 2-methoxyestradiol-induced growth suppression and lethality in estrogen-responsive MCF-7 cells may be mediated by down regulation of p34cdc2 and cyclin B1 expression. Zoubine MN, Weston AP, Johnson DC, Campbell DR, Banerjee SK. Int J Oncol; 1999 Oct 15; 15(4):639-46. PubMed ID: 10493943 [Abstract] [Full Text] [Related]
5. Estrogen and soy isoflavonoids decrease sensitivity of medulloblastoma and central nervous system primitive neuroectodermal tumor cells to chemotherapeutic cytotoxicity. Belcher SM, Burton CC, Cookman CJ, Kirby M, Miranda GL, Saeed FO, Wray KE. BMC Pharmacol Toxicol; 2017 Sep 06; 18(1):63. PubMed ID: 28877739 [Abstract] [Full Text] [Related]
6. 2-methoxyestradiol enhances p53 protein transduction therapy-associated inhibition of the proliferation of oral cancer cells through the suppression of NFkappaB activity. Takata H, Tomizawa K, Matsushita M, Matsui H. Acta Med Okayama; 2004 Aug 06; 58(4):181-7. PubMed ID: 15551755 [Abstract] [Full Text] [Related]
7. Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin. Janss AJ, Maity A, Tang CB, Muschel RJ, McKenna WG, Sutton L, Phillips PC. Neuro Oncol; 2001 Jan 06; 3(1):11-21. PubMed ID: 11305412 [Abstract] [Full Text] [Related]
8. 2-Methoxyestradiol-induced caspase-3 activation and apoptosis occurs through G(2)/M arrest dependent and independent pathways in gastric carcinoma cells. Lin HL, Liu TY, Wu CW, Chi CW. Cancer; 2001 Aug 01; 92(3):500-9. PubMed ID: 11505393 [Abstract] [Full Text] [Related]
9. p53 gene expression and 2-methoxyestradiol treatment differentially induce nuclear factor kappa B activation in human lung cancer cells with different p53 phenotypes. Rath PC, Mukhopadhyay T. DNA Cell Biol; 2009 Dec 01; 28(12):615-23. PubMed ID: 19715480 [Abstract] [Full Text] [Related]
10. Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro. Macaulay RJ, Wang W, Dimitroulakos J, Becker LE, Yeger H. J Neurooncol; 1999 Mar 01; 42(1):1-11. PubMed ID: 10360474 [Abstract] [Full Text] [Related]
11. Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways. Ray G, Dhar G, Van Veldhuizen PJ, Banerjee S, Saxena NK, Sengupta K, Banerjee SK. Biochemistry; 2006 Mar 21; 45(11):3703-13. PubMed ID: 16533053 [Abstract] [Full Text] [Related]
12. Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate. Stockhammer G, Manley GT, Johnson R, Rosenblum MK, Samid D, Lieberman FS. J Neurosurg; 1995 Oct 21; 83(4):672-81. PubMed ID: 7674018 [Abstract] [Full Text] [Related]
13. Enhancement of radiation effects in vitro by the estrogen metabolite 2-methoxyestradiol. Amorino GP, Freeman ML, Choy H. Radiat Res; 2000 Apr 21; 153(4):384-91. PubMed ID: 10760997 [Abstract] [Full Text] [Related]
14. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Shimada K, Nakamura M, Ishida E, Kishi M, Konishi N. Carcinogenesis; 2003 Jun 21; 24(6):1067-75. PubMed ID: 12807754 [Abstract] [Full Text] [Related]
15. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy. Prados MD, Wara W, Edwards MS, Ater J, Rabbit J, Lamborn K, Davis R, Levin VA. Pediatr Neurosurg; 1996 Oct 21; 25(4):174-81. PubMed ID: 9293544 [Abstract] [Full Text] [Related]
16. The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors. Schumacher G, Neuhaus P. J Cancer Res Clin Oncol; 2001 Jul 21; 127(7):405-10. PubMed ID: 11469676 [Abstract] [Full Text] [Related]
17. In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood. Trojanowski JQ, Fung KM, Rorke LB, Tohyama T, Yachnis AT, Lee VM. Mol Chem Neuropathol; 1994 Jul 21; 21(2-3):219-39. PubMed ID: 8086035 [Abstract] [Full Text] [Related]
18. Combination of 2-methoxyestradiol (2-ME2) and eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells. Ghosh R, Ganapathy M, Alworth WL, Chan DC, Kumar AP. J Steroid Biochem Mol Biol; 2009 Jan 21; 113(1-2):25-35. PubMed ID: 19084597 [Abstract] [Full Text] [Related]
19. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis. Kar S, Wang M, Carr BI. Cancer Chemother Pharmacol; 2008 Oct 21; 62(5):831-40. PubMed ID: 18246350 [Abstract] [Full Text] [Related]
20. 2-methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells. Maran A, Zhang M, Kennedy AM, Sibonga JD, Rickard DJ, Spelsberg TC, Turner RT. Bone; 2002 Feb 21; 30(2):393-8. PubMed ID: 11856647 [Abstract] [Full Text] [Related] Page: [Next] [New Search]